Zelira Therapeutics Limited (ZLDAF)

Zelira Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 20, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	2	3	2	11	6	38
Market Cap Growth	-58.14%	61.90%	-81.41%	78.17%	-83.32%	6.52%
Enterprise Value	4	8	3	12	2	32
Last Close Price	0.22	0.28	0.19	0.98	0.68	6.30
PS Ratio	5621.69	7979.80	33.46	56.90	6.03	77.16
PB Ratio	-0.86	-1.22	-0.76	0.54	0.26	1.35
P/TBV Ratio	-	-	-	70.09	2.66	8.59
EV/Sales Ratio	-	18174.22	54.68	58.87	1.88	64.93
Debt / Equity Ratio	-0.50	-0.50	-1.43	0.01	0.01	0.02
Asset Turnover	0	0	0.01	0.01	0.04	0.02
Inventory Turnover	0.93	0.93	0.24	0.36	0.67	-
Quick Ratio	0.01	0.01	0.41	0.08	1.85	4.68
Current Ratio	0.11	0.11	0.60	0.94	3.12	5.66
Return on Equity (ROE)	-	-	-266.82%	-18.60%	-33.77%	-23.62%
Return on Assets (ROA)	-83.30%	-83.30%	-18.87%	-12.51%	-21.42%	-15.60%
Return on Capital (ROIC)	-	-	-21.73%	-13.10%	-22.14%	-15.94%
Earnings Yield	-98.39%	-69.30%	-1150.98%	-32.53%	-128.58%	-16.70%
FCF Yield	-	-93.74%	-138.13%	-42.31%	-101.48%	-16.84%
Buyback Yield / Dilution	-1.20%	-1.20%	-12.70%	-25.19%	-21.25%	-36.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.